Creatine is often emphasized as an important component of early life nutrition. Here, we quantified the amount of creatine consumed through a regular diet among US children aged 0–2 years using data from the 2017 to 2018 National Health and Nutrition Examination Survey (NHANES).
We just have started another randomized controlled trial with herbal extract PhytoDyNAmic! Now, we aim to explore the effects of 6-month supplementation with 8-herbs extract on mitochondrial function, telomere length, and chronic inflammation in men and women aged 65 years and older.
Upregulating CT1 by various agents could be perceived as an up-and-coming target in experimental and clinical nutrition, yet its clinical efficacy, safety and feasibility require a rather careful scrutinization in the forthcoming years.
In a recent issue of Asian Journal of Psychiatry, we presented a pragmatic hypothesis that the inclusion of GAA might offer an additional benefit in profiling inflammation-oxidative stress in schizophrenia. GAA levels in the brain, cerebrospinal fluid, serum, and urine are responsive to various brain conditions.
Clinical applications of molecular hydrogen seem to favorably affect obesity-related metabolic biomarkers in peripheral tissues, yet whether H2 directly tackles obesity pathways in the brain remains elusive. We summarized several molecular targets in the hypothalamus and beyond that could be altered by H2 gas in obesity in a new paper just published in Trends in Endocrinology and Metabolism.
Our new paper published few days ago in Current Topics In Nutraceutical Research provides an update on specific nutraceuticals that are reported to modulate AGAT activity and discusses possible implications of targeting this enzyme in experimental and clinical nutrition.
Our paper on comparative molecular docking studies on creatine and guanidinoacetic acid (GAA) has been published in Journal of Chemical Research. Docking and density functional theory studies are carried out for muscle creatine kinase, and the changes in the geometries of the ligands before and after binding to the enzyme are investigated.
Our recent study published in Nutrition Research describes the effects of L-carnosine administration on various patient- and clinician-reported outcomes in a case series of patients with multiple sclerosis (MS). L-carnosine was administered orally for 8 weeks in two women and one man suffering from MS.
The book on bioenergetics edited by Professor Ostojic has just been published for Elsevier! Clinical Bioenergetics: From Pathophysiology to Clinical Translation provides recent developments surrounding the etiology and pathophysiology of inherited and acquired energy-delated disorders. Across 40 chapters, world leaders in bioenergetics and mitochondrial medicine discuss novel methodologies designed to identify deficiencies in cellular bioenergetics
We have continued scrutinization of L-carnosine in ABL! This time, we profile the single-dose pharmacokinetics of L-carnosine in healthy men in aim to compare the time course of its absorption, bioavailability, distribution, metabolism and excretion vs. traditional carnosine. The phase 0 study may help us to better determine the half-life of this nutritional additive and perhaps establish the most appropriate dosing regimen.
